219 related articles for article (PubMed ID: 30605266)
1. Quantitative in vivo proton MR spectroscopic assessment of lipid metabolism: Value for breast cancer diagnosis and prognosis.
Thakur SB; Horvat JV; Hancu I; Sutton OM; Bernard-Davila B; Weber M; Oh JH; Marino MA; Avendano D; Leithner D; Brennan S; Giri D; Manderski E; Morris EA; Pinker K
J Magn Reson Imaging; 2019 Jul; 50(1):239-249. PubMed ID: 30605266
[TBL] [Abstract][Full Text] [Related]
2. Fat Composition Measured by Proton Spectroscopy: A Breast Cancer Tumor Marker?
Bitencourt A; Sevilimedu V; Morris EA; Pinker K; Thakur SB
Diagnostics (Basel); 2021 Mar; 11(3):. PubMed ID: 33801022
[TBL] [Abstract][Full Text] [Related]
3. Solid bone tumors of the spine: Diagnostic performance of apparent diffusion coefficient measured using diffusion-weighted MRI using histology as a reference standard.
Pozzi G; Albano D; Messina C; Angileri SA; Al-Mnayyis A; Galbusera F; Luzzati A; Perrucchini G; Scotto G; Parafioriti A; Zerbi A; Sconfienza LM
J Magn Reson Imaging; 2018 Apr; 47(4):1034-1042. PubMed ID: 28755383
[TBL] [Abstract][Full Text] [Related]
4. Proton MR spectroscopy in the breast: Technical innovations and clinical applications.
Fardanesh R; Marino MA; Avendano D; Leithner D; Pinker K; Thakur SB
J Magn Reson Imaging; 2019 Oct; 50(4):1033-1046. PubMed ID: 30848037
[TBL] [Abstract][Full Text] [Related]
5. Three-dimensional proton MR spectroscopic imaging at 3 T for the differentiation of benign and malignant breast lesions.
Gruber S; Debski BK; Pinker K; Chmelik M; Grabner G; Helbich T; Trattnig S; Bogner W
Radiology; 2011 Dec; 261(3):752-61. PubMed ID: 21998046
[TBL] [Abstract][Full Text] [Related]
6. Study of single voxel 1H MR spectroscopy of bone tumors: differentiation of benign from malignant tumors.
Zhang J; Cheng K; Ding Y; Liang W; Ding Y; Vanel D; Cheng X
Eur J Radiol; 2013 Dec; 82(12):2124-8. PubMed ID: 22169357
[TBL] [Abstract][Full Text] [Related]
7. Application value of 3T ¹H-magnetic resonance spectroscopy in diagnosing breast tumors.
Vassiou K; Tsougos I; Kousi E; Vlychou M; Athanasiou E; Theodorou K; Arvanitis DL; Fezoulidis IV
Acta Radiol; 2013 May; 54(4):380-8. PubMed ID: 23436823
[TBL] [Abstract][Full Text] [Related]
8. Combined dynamic contrast enhanced breast MR and proton spectroscopic imaging: a feasibility study.
Jacobs MA; Barker PB; Argani P; Ouwerkerk R; Bhujwalla ZM; Bluemke DA
J Magn Reson Imaging; 2005 Jan; 21(1):23-8. PubMed ID: 15611934
[TBL] [Abstract][Full Text] [Related]
9. Multimodality fMRI with perfusion, diffusion-weighted MRI and
Zhu L; Wang J; Shi H; Tao X
J Magn Reson Imaging; 2019 Feb; 49(2):423-432. PubMed ID: 30475438
[TBL] [Abstract][Full Text] [Related]
10. Comparative Investigation of Single Voxel Magnetic Resonance Spectroscopy and Dynamic Contrast Enhancement MR Imaging in Differentiation of Benign and Malignant Breast Lesions in a Sample of Iranian Women.
Faeghi F; Baniasadipour B; Jalalshokouhi J
Asian Pac J Cancer Prev; 2015; 16(18):8335-8. PubMed ID: 26745081
[TBL] [Abstract][Full Text] [Related]
11. Diffusion Kurtosis at 3.0T as an in vivo Imaging Marker for Breast Cancer Characterization: Correlation With Prognostic Factors.
Huang Y; Lin Y; Hu W; Ma C; Lin W; Wang Z; Liang J; Ye W; Zhao J; Wu R
J Magn Reson Imaging; 2019 Mar; 49(3):845-856. PubMed ID: 30260589
[TBL] [Abstract][Full Text] [Related]
12.
Montemezzi S; Cavedon C; Camera L; Meliadò G; Caumo F; Baglio I; Sardanelli F
Radiol Med; 2017 Mar; 122(3):161-170. PubMed ID: 27981485
[TBL] [Abstract][Full Text] [Related]
13. Study of lipid metabolism by estimating the fat fraction in different breast tissues and in various breast tumor sub-types by in vivo
Agarwal K; Sharma U; Mathur S; Seenu V; Parshad R; Jagannathan NR
Magn Reson Imaging; 2018 Jun; 49():116-122. PubMed ID: 29454110
[TBL] [Abstract][Full Text] [Related]
14. Determination of choline concentration in breast lesions: quantitative multivoxel proton MR spectroscopy as a promising noninvasive assessment tool to exclude benign lesions.
Dorrius MD; Pijnappel RM; Jansen-van der Weide MC; Jansen L; Kappert P; Oudkerk M; Sijens PE
Radiology; 2011 Jun; 259(3):695-703. PubMed ID: 21460033
[TBL] [Abstract][Full Text] [Related]
15. Retrospective phase-based gating for cardiac proton spectroscopy with fixed scan time.
Gastl M; Peereboom SM; Fuetterer M; Boenner F; Kelm M; Manka R; Kozerke S
J Magn Reson Imaging; 2019 Dec; 50(6):1973-1981. PubMed ID: 31125172
[TBL] [Abstract][Full Text] [Related]
16. In vivo proton magnetic resonance spectroscopy of large focal hepatic lesions and metabolite change of hepatocellular carcinoma before and after transcatheter arterial chemoembolization using 3.0-T MR scanner.
Kuo YT; Li CW; Chen CY; Jao J; Wu DK; Liu GC
J Magn Reson Imaging; 2004 May; 19(5):598-604. PubMed ID: 15112309
[TBL] [Abstract][Full Text] [Related]
17. High-field MR spectroscopy in the multiparametric MRI evaluation of breast lesions.
Cavedon C; Meliadò G; Rossi L; Camera L; Baglio I; Caumo F; Montemezzi S
Phys Med; 2016 Dec; 32(12):1707-1711. PubMed ID: 27637861
[TBL] [Abstract][Full Text] [Related]
18. Multiparametric MRI model with dynamic contrast-enhanced and diffusion-weighted imaging enables breast cancer diagnosis with high accuracy.
Zhang M; Horvat JV; Bernard-Davila B; Marino MA; Leithner D; Ochoa-Albiztegui RE; Helbich TH; Morris EA; Thakur S; Pinker K
J Magn Reson Imaging; 2019 Mar; 49(3):864-874. PubMed ID: 30375702
[TBL] [Abstract][Full Text] [Related]
19. Proton magnetic resonance spectroscopic imaging of human breast cancer: a preliminary study.
Jacobs MA; Barker PB; Bottomley PA; Bhujwalla Z; Bluemke DA
J Magn Reson Imaging; 2004 Jan; 19(1):68-75. PubMed ID: 14696222
[TBL] [Abstract][Full Text] [Related]
20. TE = 32 ms vs TE = 100 ms echo-time (1)H-magnetic resonance spectroscopy in prostate cancer: Tumor metabolite depiction and absolute concentrations in tumors and adjacent tissues.
Basharat M; Payne GS; Morgan VA; Parker C; Dearnaley D; deSouza NM
J Magn Reson Imaging; 2015 Oct; 42(4):1086-93. PubMed ID: 26258905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
